Karen Smith
Nurse Practitioner · Terre Haute, INNPI 1538150974
Payments from drug & device makers
Across 115 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$269
- Boehringer Ingelheim$209
- Lilly USA, LLC$162
- Mannkind Corporation$126
- Dexcom, Inc.$120
- AbbVie$106
- plus $920 from 21 others
What the payments were for
- Food & beverage$1,913100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $269 |
| Boehringer Ingelheim | 11 | $209 |
| Lilly USA, LLC | 9 | $162 |
| Mannkind Corporation | 3 | $126 |
| Dexcom, Inc. | 7 | $120 |
| AbbVie | 7 | $106 |
| Medtronic | 6 | $94 |
| AstraZeneca | 5 | $81 |
| Corcept Therapeutics | 4 | $76 |
| Novartis | 4 | $73 |
| Merck | 4 | $60 |
| Abbott | 4 | $59 |
| Amgen(2 entities) | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 3 | $51 |
| Pfizer | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Insulet Corporation | 2 | $40 |
| Avanos Medical | 1 | $37 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Bayer | 2 | $34 |
| Johnson & Johnson | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Halozyme Inc | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $13 |
| Recordati_rare_diseases_inc. | 1 | $13 |
| Zealand Pharma US, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFREZZA$106
How this compares
$1,913 in reported general payments places this provider in the 80th percentile of 2,724 nurse practitioner providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 177 | $188,946 |
| JardianceEmpagliflozin | 178 | $160,885 |
| TrulicityDulaglutide | 104 | $115,272 |
| FarxigaDapagliflozin Propanediol | 118 | $109,102 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 64 | $85,611 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 80 | $72,151 |
| MounjaroTirzepatide | 61 | $66,315 |
| Tresiba Flextouch U-100Insulin Degludec | 115 | $62,113 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 26 | $52,976 |
| JanuviaSitagliptin Phosphate | 44 | $49,103 |
| Tresiba Flextouch U-200Insulin Degludec | 45 | $48,048 |
| Novolog FlexpenInsulin Aspart | 137 | $41,116 |
| Bydureon BciseExenatide Microspheres | 29 | $39,114 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $36,240 |
| InvokanaCanagliflozin | 24 | $32,275 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Fiasp, Novolog | $269 | $227,225232 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $162 | $188,871192 claims |
| Boehringer IngelheimJardiance, Tradjenta | $209 | $170,317191 claims |
| AstraZenecaFarxiga | $81 | $109,102118 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $28 | $72,15180 claims |
| MerckJanuvia, Janumet Xr | $60 | $59,66959 claims |
| Johnson & JohnsonInvokana | $33 | $32,27524 claims |
| AbbVieSynthroid | $106 | $18,498221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Terre Haute
- Lindsay GambleTerre Haute$13K
- Kindra ShepardTerre Haute$12K
- Lisa FergusonTerre Haute$11K
- Ashley McCammonTerre Haute$9K
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.